Unicharm Corporation (8113) Free Cash Flow 2021–2025

Name: Unicharm Corporation (8113) free cash flow history 2021-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-12

Unicharm Corporation annual free cash flow for fiscal 2025 was JPY 102.8 billion, an increase of 5.2% from JPY 97.8 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

8113 Annual Free Cash Flow

Free Cash Flow (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	JPY 102.8B	JPY 97.8B	JPY 124.0B	JPY 59.3B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

8113 Quarterly Free Cash Flow

Free Cash Flow (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Free Cash Flow	JPY 26.9B	JPY 23.7B	JPY 35.2B	JPY 22.9B	JPY 24.0B	—	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Free Cash Flow at Comparable Companies

4452 Free Cash Flow — Kao Corporation
4911 Free Cash Flow — Shiseido Company, Limited
4527 Free Cash Flow — Rohto Pharmaceutical Co.,Ltd.
4912 Free Cash Flow — Lion Corporation
4967 Free Cash Flow — Kobayashi Pharmaceutical Co., Ltd.
8283 Free Cash Flow — Paltac Corporation

More 8113 metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS

All 8113 financial statements → Interactive 8113 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.